BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: MicroRNA-186-5p (miR-186-5p); chemokine CXC motif ligand 13 (CXCL13); CXC chemokine receptor 5 (CXCR5)

January 28, 2016 8:00 AM UTC

Mouse studies suggest promoting miR-186-5p expression or inhibiting CXCL13-CXCR5 signaling could help treat neuropathic pain. A mouse model of spinal nerve ligation-induced neuropathic pain had lower ...